Amazon's $3.9B Purchase of 1Life's One Medical Faces Delay Due to FTC Investigation
Amazon's $3.9B Purchase of 1Life's One Medical Faces Delay Due to FTC Investigation
The Federal Trade Commission (FTC) is investigating the $3.9 billion transaction between $Amazon (AMZN.US)$ and $1Life Healthcare (ONEM.US)$.
這個聯邦貿易委員會美國聯邦貿易委員會(FTC)正在調查這筆39億美元的交易$亞馬遜 (AMZN.US)$和$1Life Healthcare (ONEM.US)$.
What Happened: According to a filing with the U.S. Securities and Exchange Commission, the FTC sent a notice to each company requesting "additional information and documentary materials" about the deal.
怎麼了：根據提交給美國聯邦調查局的一份文件美國證券交易委員會聯邦貿易委員會向每家公司發出通知，要求提供有關這筆交易的“額外信息和文件材料”。
Amazon first announced a deal for One Medical, a primary care provider owned by 1Life, in July. The Seattle-based e-commerce giant reportedly outbid $CVS Health (CVS.US)$ in an auction process.
今年7月，亞馬遜首次宣佈與1Life旗下的初級保健提供商One Medical達成交易。據報道，這家總部位於西雅圖的電商巨頭出價高於$西維斯健康 (CVS.US)$在拍賣過程中。
Why It's Important: A federal probe like this one may delay the acquisition process.
為什麼它很重要：像這樣的聯邦調查可能會推遲收購進程。
The request extends the waiting period imposed by the Hart-Scott-Rodino Act "until 30 days after One Medical and Amazon have substantially complied with the Second Request, unless that period is extended voluntarily by the parties or terminated sooner by the FTC," the filing stated.
文件稱，該請求將哈特-斯科特-羅迪諾法案規定的等待期延長至“One Medical和亞馬遜基本上遵守第二項請求後30天，除非雙方自願延長或聯邦貿易委員會更早終止該期限”。
The news is also a hiccup for Amazon CEO Andy Jassy, who took the helm from founder Jeff Bezos in July 2021. One of Jassy's goals is to bolster Amzon's healthcare offerings. The One Medical deal, Jassy's first major M&A move as CEO, would give Amazon ownership of some 180 clinics.
這一消息對亞馬遜首席執行官來説也是一個小問題安迪·賈西，他從方正手中接過了方向盤Jeff·貝佐斯2021年7月。Jassy的目標之一是支持Amzon的醫療服務。One Medical的交易是賈西就任首席執行官後的第一次重大併購行動，它將使亞馬遜擁有大約180家診所。
Price Target: Amazon closed Friday at $127.51 per share — down 0.24%. Meanwhile, 1Life closed at $17.40 a share — up 0.35%.
目標價格：亞馬遜週五收於每股127.51美元，下跌0.24%.與此同時，1Life收盤報每股17.40美元，上漲0.35%。